Skip to main content
Erschienen in: Archives of Dermatological Research 9/2009

01.09.2009 | Short Communication

Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma

verfasst von: Natasa Colovic, Vladimir Jurisic, Tatjana Terzic, Henry Dushan Atkinson, Milica Colovic

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

The case of a 44-year-old man with a primary cutaneous large B-cell non-Hodgkin’s lymphoma of the scalp is reported. His mother died of gastric lymphoma and his sib brother is in a 20-year remission of T-cell lymphoma. The patient presented with a 16-year history of occipital and parietal alopecia and a recently worsening scalp rash. The histopathology and immunohistochemistry performed in April 2006 indicated a bcl-6+, MUM− and bcl-2−, primary cutaneous follicle center B-cell non-Hodgkin’s lymphoma, with an aggressive transformation to a diffuse large B-cell lymphoma. Bone marrow biopsy and CT chest, abdomen, and pelvis were negative for systemic lymphoma. The patient had an excellent clinical and histological resolution following 8 cycles of rituximab and CHOP protocol immunochemotherapy, and remains in complete remission until now. The protracted indolent phase of the disease, the familial history of lymphoma, the histological aggressive features and the patient’s excellent response to immunochemotherapy all contribute to a very unusual manifestation of this disease.
Literatur
1.
Zurück zum Zitat Altieri A, Lorenzo Bermejo J, Hemminki K (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:668–672. doi:10.1182/blood-2005-01-0140 PubMedCrossRef Altieri A, Lorenzo Bermejo J, Hemminki K (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:668–672. doi:10.​1182/​blood-2005-01-0140 PubMedCrossRef
2.
Zurück zum Zitat Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S (2005) WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647–674. doi:10.1111/j.0303-6987.2005.00495.x PubMedCrossRef Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S (2005) WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647–674. doi:10.​1111/​j.​0303-6987.​2005.​00495.​x PubMedCrossRef
3.
4.
Zurück zum Zitat Jaffe ES, Harris NL, Stein H, Vardiman JWE (eds) (2001) World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, PA Jaffe ES, Harris NL, Stein H, Vardiman JWE (eds) (2001) World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, PA
6.
Zurück zum Zitat Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J (2000) Primary cutaneous B cell lymphoma: review and current concepts. J Clin Oncol 18:2152–2168PubMed Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J (2000) Primary cutaneous B cell lymphoma: review and current concepts. J Clin Oncol 18:2152–2168PubMed
7.
Zurück zum Zitat Piccino R, Caccialanza M, Berti E, Baldini L (1993) Radiotherapy of cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys 27:385–389 Piccino R, Caccialanza M, Berti E, Baldini L (1993) Radiotherapy of cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys 27:385–389
10.
Zurück zum Zitat Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Roodriquez AM, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F (2001) Primary cutaneous non-Hodgkin’s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol 19(2):398–405PubMed Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Roodriquez AM, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F (2001) Primary cutaneous non-Hodgkin’s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol 19(2):398–405PubMed
11.
Zurück zum Zitat Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris HA (2002) Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 13:1290–1299. doi:10.1093/annonc/mdf206 PubMedCrossRef Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris HA (2002) Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 13:1290–1299. doi:10.​1093/​annonc/​mdf206 PubMedCrossRef
12.
Zurück zum Zitat Willemze R, Jaffe SE, Burg G, Ceroni L, Berti E, Swerdow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Dunkan LM, Grange F, Harris Lee N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Wermeer MH, Wechler J, Whittaker S, Meijr JLMC (2005) WHO-EORTC classification for cutaneous lymphoma. Blood 105:3768–3785. doi:10.1182/blood-2004-09-3502 PubMedCrossRef Willemze R, Jaffe SE, Burg G, Ceroni L, Berti E, Swerdow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Dunkan LM, Grange F, Harris Lee N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Wermeer MH, Wechler J, Whittaker S, Meijr JLMC (2005) WHO-EORTC classification for cutaneous lymphoma. Blood 105:3768–3785. doi:10.​1182/​blood-2004-09-3502 PubMedCrossRef
13.
Zurück zum Zitat Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371PubMed Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371PubMed
Metadaten
Titel
Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma
verfasst von
Natasa Colovic
Vladimir Jurisic
Tatjana Terzic
Henry Dushan Atkinson
Milica Colovic
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2009
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-009-0967-1

Weitere Artikel der Ausgabe 9/2009

Archives of Dermatological Research 9/2009 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.